These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 2440483)
1. Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Minderaa RB; Anderson GM; Volkmar FR; Akkerhuis GW; Cohen DJ Biol Psychiatry; 1987 Aug; 22(8):933-40. PubMed ID: 2440483 [TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals. Mulder EJ; Anderson GM; Kemperman RF; Oosterloo-Duinkerken A; Minderaa RB; Kema IP Neuropsychobiology; 2010; 61(1):27-32. PubMed ID: 19923863 [TBL] [Abstract][Full Text] [Related]
3. Hyperserotonemia and amine metabolites in autistic and retarded children. Hanley HG; Stahl SM; Freedman DX Arch Gen Psychiatry; 1977 May; 34(5):521-31. PubMed ID: 860890 [TBL] [Abstract][Full Text] [Related]
4. Whole blood serotonin and tryptophan in autism: temporal stability and the effects of medication. Minderaa RB; Anderson GM; Volkmar FR; Harcherick D; Akkerhuis GW; Cohen DJ J Autism Dev Disord; 1989 Mar; 19(1):129-36. PubMed ID: 2708296 [TBL] [Abstract][Full Text] [Related]
5. Whole blood serotonin in autistic and normal subjects. Anderson GM; Freedman DX; Cohen DJ; Volkmar FR; Hoder EL; McPhedran P; Minderaa RB; Hansen CR; Young JG J Child Psychol Psychiatry; 1987 Nov; 28(6):885-900. PubMed ID: 3436995 [TBL] [Abstract][Full Text] [Related]
6. Blood serotonin and free tryptophan concentration in autistic children. Hoshino Y; Yamamoto T; Kaneko M; Tachibana R; Watanabe M; Ono Y; Kumashiro H Neuropsychobiology; 1984; 11(1):22-7. PubMed ID: 6204248 [TBL] [Abstract][Full Text] [Related]
7. Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Croonenberghs J; Delmeire L; Verkerk R; Lin AH; Meskal A; Neels H; Van der Planken M; Scharpe S; Deboutte D; Pison G; Maes M Neuropsychopharmacology; 2000 Mar; 22(3):275-83. PubMed ID: 10693155 [TBL] [Abstract][Full Text] [Related]
8. Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. Launay JM; Ferrari P; Haimart M; Bursztejn C; Tabuteau F; Braconnier A; Pasques-Bondoux D; Luong C; Dreux C Neuropsychobiology; 1988; 20(1):1-11. PubMed ID: 2466221 [TBL] [Abstract][Full Text] [Related]
9. Ontogeny of brain and blood serotonin levels in 5-HT receptor knockout mice: potential relevance to the neurobiology of autism. Janusonis S; Anderson GM; Shifrovich I; Rakic P J Neurochem; 2006 Nov; 99(3):1019-31. PubMed ID: 16981893 [TBL] [Abstract][Full Text] [Related]
10. Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Croonenberghs J; Verkerk R; Scharpe S; Deboutte D; Maes M Life Sci; 2005 Mar; 76(19):2171-83. PubMed ID: 15733932 [TBL] [Abstract][Full Text] [Related]
11. Neurochemical study of dopamine functioning in autistic and normal subjects. Minderaa RB; Anderson GM; Volkmar FR; Akkerhuis GW; Cohen DJ J Am Acad Child Adolesc Psychiatry; 1989 Mar; 28(2):190-4. PubMed ID: 2925571 [TBL] [Abstract][Full Text] [Related]
12. Indoleamine compartmentation in human blood. Demet EM; Halaris AE; Bhatarakamol S Clin Chim Acta; 1978 Oct; 89(2):285-92. PubMed ID: 709877 [TBL] [Abstract][Full Text] [Related]
13. Effects of inhibition of serotonin synthesis on 5-hydroxyindoleacetic acid excretion, in healthy subjects. Alfieri AB; Cubeddu LX J Clin Pharmacol; 1994 Feb; 34(2):153-7. PubMed ID: 7512997 [TBL] [Abstract][Full Text] [Related]
15. [The application of 5-HT and 5-HIAA in the diagnosis of apudomas]. Xu SH; Chen YF; Chen HC Zhonghua Nei Ke Za Zhi; 1990 Jul; 29(7):428-31, 446. PubMed ID: 1704304 [TBL] [Abstract][Full Text] [Related]
16. [Metabolism of serotonin in autism in children]. Bursztejn C; Ferrari P; Dreux C; Braconnier A; Lancrenon S Encephale; 1988; 14(6):413-9. PubMed ID: 3068046 [TBL] [Abstract][Full Text] [Related]
17. [Urinary excretion of 5-hydroxyindoleacetic acid and serum tryptophan and serotonin levels in patients with depression]. Pietruszewska I; Jasińska M; Lewicka-Wysocka H; Marcjan K; Stencka K Psychiatr Pol; 1984; 18(1):9-16. PubMed ID: 6204348 [No Abstract] [Full Text] [Related]
18. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron. Castejon AM; Paez X; Hernandez L; Cubeddu LX J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811 [TBL] [Abstract][Full Text] [Related]
19. On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression. Amamoto T; Sarai K Hiroshima J Med Sci; 1976 Sep; 25(2-3):135-40. PubMed ID: 1088369 [No Abstract] [Full Text] [Related]
20. Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and tryptophan in plasma and urine by HPLC with fluorimetric detection. Bearcroft CP; Farthing MJ; Perrett D Biomed Chromatogr; 1995; 9(1):23-7. PubMed ID: 7537559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]